These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20615952)

  • 1. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
    de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of the microsomal tamoxifen binding site.
    Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
    J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol epoxide hydrolase and cancer.
    Silvente-Poirot S; Poirot M
    Curr Opin Pharmacol; 2012 Dec; 12(6):696-703. PubMed ID: 22917620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.
    Silvente-Poirot S; de Medina P; Record M; Poirot M
    Biochimie; 2016 Nov; 130():109-114. PubMed ID: 27262406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.
    de Medina P; Paillasse MR; Ségala G; Khallouki F; Brillouet S; Dalenc F; Courbon F; Record M; Poirot M; Silvente-Poirot S
    Chem Phys Lipids; 2011 Sep; 164(6):432-7. PubMed ID: 21641337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
    Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
    Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
    Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
    Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
    Watts CK; Sutherland RL
    Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.
    de Medina P; Silvente-Poirot S; Poirot M
    Autophagy; 2009 Oct; 5(7):1066-7. PubMed ID: 19738414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites.
    Hwang PL
    Biochim Biophys Acta; 1990 Feb; 1033(2):154-61. PubMed ID: 2306459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases.
    de Medina P; Ayadi S; Diallo K; Buñay J; Pucheu L; Soulès R; Record M; Brillouet S; Vija L; Courbon F; Silvente-Poirot S; Poirot M
    Adv Exp Med Biol; 2024; 1440():149-161. PubMed ID: 38036879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site.
    Mésange F; Sebbar M; Kedjouar B; Capdevielle J; Guillemot JC; Ferrara P; Bayard F; Delarue F; Faye JC; Poirot M
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):107-12. PubMed ID: 9693109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS.
    Soules R; Noguer E; Iuliano L; Zerbinati C; Leignadier J; Rives A; de Medina P; Silvente-Poirot S; Poirot M
    Chem Phys Lipids; 2017 Oct; 207(Pt B):92-98. PubMed ID: 28554594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor.
    Kedjouar B; Daunes S; Vilner BJ; Bowen WD; Klaebe A; Faye JC; Poirot M
    Biochem Pharmacol; 1999 Dec; 58(12):1927-39. PubMed ID: 10591147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone.
    Mésange F; Sebbar M; Capdevielle J; Guillemot JC; Ferrara P; Bayard F; Poirot M; Faye JC
    Bioconjug Chem; 2002; 13(4):766-72. PubMed ID: 12121132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
    Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
    Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate.
    de Médina P; Ayadi S; Soulès R; Payre B; Rup-Jacques S; Silvente-Poirot S; Samadi M; Poirot M
    J Steroid Biochem Mol Biol; 2023 Nov; 234():106396. PubMed ID: 37683773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
    Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
    Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor.
    Voisin M; de Medina P; Mallinger A; Dalenc F; Huc-Claustre E; Leignadier J; Serhan N; Soules R; Ségala G; Mougel A; Noguer E; Mhamdi L; Bacquié E; Iuliano L; Zerbinati C; Lacroix-Triki M; Chaltiel L; Filleron T; Cavaillès V; Al Saati T; Rochaix P; Duprez-Paumier R; Franchet C; Ligat L; Lopez F; Record M; Poirot M; Silvente-Poirot S
    Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9346-E9355. PubMed ID: 29078321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.